Cargando…

Stromal Expression of MiR-21 Predicts Biochemical Failure in Prostate Cancer Patients with Gleason Score 6

AIM: microRNAs (miRNAs) are involved in various neoplastic diseases, including prostate cancer (PCs). The aim of this study was to investigate the miRNA profile in PC tissue, to assess their association with clinicopathologic data, and to evaluate the potential of miRNAs as diagnostic and prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melbø-Jørgensen, Christian, Ness, Nora, Andersen, Sigve, Valkov, Andrej, Dønnem, Tom, Al-Saad, Samer, Kiselev, Yury, Berg, Thomas, Nordby, Yngve, Bremnes, Roy M., Busund, Lill-Tove, Richardsen, Elin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234532/ https://www.ncbi.nlm.nih.gov/pubmed/25401698 http://dx.doi.org/10.1371/journal.pone.0113039

Ejemplares similares

MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer
por: Richardsen, Elin, et al.
Publicado: (2019)

High miR-205 expression in normal epithelium is associated with biochemical failure - an argument for epithelial crosstalk in prostate cancer?
por: Nordby, Yngve, et al.
Publicado: (2017)

The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort
por: Ness, Nora, et al.
Publicado: (2017)

High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure
por: Grindstad, Thea, et al.
Publicado: (2015)

Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer – a multicenter (in situ hybridization) study
por: Andersen, Sigve, et al.
Publicado: (2016)

Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression
por: Grindstad, Thea, et al.
Publicado: (2018)

High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence
por: Nordby, Yngve, et al.
Publicado: (2017)

Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
por: Richardsen, Elin, et al.
Publicado: (2017)

Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome
por: Grindstad, Thea, et al.
Publicado: (2016)

Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time
por: Andersen, Sigve, et al.
Publicado: (2014)

The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
por: Al-Saad, Samer, et al.
Publicado: (2017)

Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
por: Eilertsen, Marte, et al.
Publicado: (2014)

High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome
por: Stenvold, Helge, et al.
Publicado: (2014)

Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer
por: Kiselev, Yury, et al.
Publicado: (2018)

Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer
por: Rakaee, Mehrdad, et al.
Publicado: (2016)

Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival
por: Hald, Sigurd M., et al.
Publicado: (2015)

Erratum to: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival
por: Hald, Sigurd M., et al.
Publicado: (2016)

Stage and tissue-specific prognostic impact of miR-182 in NSCLC
por: Stenvold, Helge, et al.
Publicado: (2014)

A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
por: Skjefstad, Kaja, et al.
Publicado: (2018)

Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma
por: Smeland, Eivind, et al.
Publicado: (2012)

Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry()
por: Rakaee, Mehrdad, et al.
Publicado: (2019)

Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival
por: Andersen, Sigve, et al.
Publicado: (2011)

Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma: VEGF-A Impact Is Strongly Associated with Ang-2
por: Andersen, Sigve, et al.
Publicado: (2011)

CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
por: Paulsen, Erna-Elise, et al.
Publicado: (2017)

Profiling of VEGFs and VEGFRs as Prognostic Factors in Soft Tissue Sarcoma: VEGFR-3 Is an Independent Predictor of Poor Prognosis
por: Kilvaer, Thomas K., et al.
Publicado: (2010)

Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer
por: Andersen, Sigve, et al.
Publicado: (2017)

CD45RO(+) Memory T Lymphocytes — a Candidate Marker for TNM-Immunoscore in Squamous Non–Small Cell Lung Cancer()
por: Paulsen, Erna-Elise, et al.
Publicado: (2015)

Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific Survival
por: Kilvaer, Thomas Karsten, et al.
Publicado: (2010)

Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients
por: Kilvaer, Thomas K, et al.
Publicado: (2011)

The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas
por: Valkov, Andrej, et al.
Publicado: (2011)

The Prognostic Impact of TGF-β1, Fascin, NF-κB and PKC-ζ Expression in Soft Tissue Sarcomas
por: Valkov, Andrej, et al.
Publicado: (2011)

The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk
por: Kilvaer, Thomas K, et al.
Publicado: (2014)

Prognostic Impact of Lymphocytes in Soft Tissue Sarcomas
por: Sorbye, Sveinung W., et al.
Publicado: (2011)

Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas
por: Sorbye, Sveinung W, et al.
Publicado: (2012)

Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas
por: Sorbye, Sveinung W., et al.
Publicado: (2012)

Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas
por: Sorbye, Sveinung W, et al.
Publicado: (2012)

Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas
por: Sorbye, Sveinung W, et al.
Publicado: (2013)

Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization
por: Donnem, Tom, et al.
Publicado: (2011)

MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer
por: Donnem, Tom, et al.
Publicado: (2012)

Digitally quantified CD8(+) cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
por: Kilvaer, Thomas K, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fduvait86nvdn874vmlcg6j4dm